Live feed08:45:00·36dPRReleasevia QuantisnowThree Nasdaq Cancer Developers Under $10 Advance Clinical ProgramsByQuantisnow·Wall Street's wire, on your screen.NTHI· NeOnc Technologies Holdings Inc.BCTX· BriaCell Therapeutics Corp.ONCY· Oncolytics Biotech Inc.Health Care
